Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Current Opinion in Neurology|February 20, 2010
Mechanisms of cerebral edema in traumatic brain injury: therapeutic developmentsJames J Donkin, Robert VinkJournal of Neurotrauma|December 24, 2010
A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injuryJames J Donkin, Ibolja Cernak, Peter C Blumbergs, et al.Progress in Brain Research|July 10, 2007
Substance P in traumatic brain injuryJames J Donkin, Renee J Turner, Islam Hassan, et al.Journal of Neuroscience Research|August 20, 2008
Validation of reference genes for normalization of real-time quantitative RT-PCR data in traumatic brain injuryNaomi L Cook, Robert Vink, James J Donkin, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 14, 2009
Substance P is associated with the development of brain edema and functional deficits after traumatic brain injuryJames J Donkin, Alan J Nimmo, Ibolja Cernak, et al.The Journal of Biological Chemistry|August 27, 2010
ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 miceJames J Donkin, Sophie Stukas, Veronica Hirsch-Reinshagen, et al.Journal of Neurotrauma|February 3, 2005
Downregulation of amyloid precursor protein (APP) expression following post-traumatic cyclosporin-A administrationCorinna Van Den Heuvel, James J Donkin, John W Finnie, et al.Pageof 1